Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

August 01, 1998; 51 (2) Brief Communications

Disseminated intravascular coagulation and status epilepticus

A. Felcher, C. Commichau, Q. Cao, M. J. Brown, A. Torres, C. W. Francis
First published August 1, 1998, DOI: https://doi.org/10.1212/WNL.51.2.629
A. Felcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Commichau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Q. Cao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. J. Brown
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Torres
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. W. Francis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Disseminated intravascular coagulation and status epilepticus
A. Felcher, C. Commichau, Q. Cao, M. J. Brown, A. Torres, C. W. Francis
Neurology Aug 1998, 51 (2) 629-631; DOI: 10.1212/WNL.51.2.629

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
137

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Status epilepticus has been associated with disseminated intravascular coagulation (DIC), but little is known regarding the pathogenesis of this uncommon association. We describe a 41-year-old woman with status epilepticus resulting in death in whom laboratory data demonstrated profound activation of the coagulation and fibrinolytic systems; autopsy findings were consistent with DIC. The occurrence of DIC in status epilepticus may be related to widespread endothelial damage secondary to seizure-induced hyperpyrexia. Body temperature should be closely monitored in patients with prolonged seizures.

Disseminated intravascular coagulation (DIC) results from excessive activation of hemostatic mechanisms and can lead to extensive bleeding, widespread microthrombus formation, shock, and death. Acute DIC is most commonly caused by overwhelming infections, massive trauma, and obstetric complications, although many clinical entities have been associated.1 Status epilepticus has been rarely reported as a cause of acute DIC.2,3 We describe a woman with fatal autopsy-confirmed DIC associated with status epilepticus; this case directs attention to careful management of hyperpyrexia.

Case report. A 41-year-old woman with a 15-year history of seizures subsequent to head trauma was diagnosed at an outside hospital with prolonged, generalized seizures. She had two prior episodes of status epilepticus 1 and 3 years previously and was currently taking phenytoin and gabapentin. She was healthy until the afternoon of the day of admission when she experienced a prolonged, witnessed generalized seizure. She initially received two doses of 10 mg lorazepam intravenously without resolution of the seizure and was treated with acetaminophen and a cooling blanket for hyperthermia with a maximum temperature of 42.5 °C. She became apneic and was intubated. Pentothal (500 mg) was administered, and her motor activity ceased after a total of 75 minutes. A phenytoin level was 0.5 mg/dL (normal, 10-20 mg/dL).

She was transferred to our hospital approximately 4.5 hours after the onset of her seizure. She was nonresponsive, intubated, and clinically in shock on arrival. Her blood pressure was 85/50, heart rate 174, and rectal temperature 40.3 °C. A large hematoma was present in the right groin near a venipuncture site, and blood was oozing from multiple venipuncture sites. She was comatose, her pupils were fixed at 3 mm bilaterally, and oculocephalic, caloric, and corneal reflexes were absent. Her muscle tone was flaccid and she had no spontaneous muscle activity or respirations. The white blood cell count was 44,800/µL, hematocrit was 44%, and platelet count had decreased to 108,000/µL from 388,000 at the outside hospital. The prothrombin time (PT) was greater than 100 seconds, and the activated partial thromboplastin time (aPTT) was more than 150 seconds. The serum creatine kinase was elevated at 3396 IU/mL. Blood smear examination revealed schistocytes. Additional hematologic laboratory data are shown in the table. A chest radiograph was normal, and urine toxicologic screen results were negative.

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table Hematologic values

Treatment included fluid resuscitation, hemodynamic pressor agents, and broad-spectrum antibiotics. She initially responded with improvement in her blood pressure but then began to bleed from multiple mucosal surfaces including her nose, eyes, nasogastric tube, and rectum. At this time repeat laboratory data demonstrated decreased fibrinogen, increased fibrinogen degradation products, and a dramatic decrease in her hematocrit to 15% and platelet count to 50,000/µL. Hematologic parameters did not improve despite multiple transfusions of red blood cells, platelets, cryoprecipitate, and fresh frozen plasma. Her bleeding and hypotension persisted, and she developed asystole and died 17 hours after arrival.

At autopsy there were widespread submucosal hematomas, a retroperitoneal hematoma, and multiple focal areas of hemorrhage of the small and large bowel. The liver also showed areas of hemorrhage and ischemia. The brain had an old scar in the right temporal lobe consistent with previous trauma, but no intraparenchymal or meningeal hemorrhages. Microscopic examination demonstrated bilateral hippocampal sclerosis consistent with long-standing epilepsy but no evidence of ischemic changes in the CA1 sector of the hippocampi or central nervous system or other infection. Blood culture results were negative after 7 days.

Further coagulation studies were performed on frozen plasma specimens (see table) and revealed evidence of a consumptive coagulopathy including prolonged PT and aPTT and decreased fibrinogen and factors VII and VIII. The concentration of soluble fibrin was markedly elevated, indicating systemic thrombin activity. Increased fibrinolytic activity was reflected by elevated concentrations of tissue plasminogen activator, fibrin(ogen) degradation products, and D-dimer.

Discussion. Our patient had a consumptive coagulopathy in the setting of status epilepticus with prolonged motor activity and hyperpyrexia. On presentation to our institution 4.5 hours after the initial episode she was in shock and coagulation studies showed evidence of systemic thrombin activity, fibrinolysis, and depletion of coagulation factors and platelets with bleeding from multiple sites. In addition, high creatinine kinase levels support the additional diagnosis of rhabdomyolysis. The autopsy findings were consistent with consumptive coagulopathy, demonstrating numerous submucosal hemorrhages and endothelial damage. There was no evidence of infection, trauma, brain damage, or toxic ingestion as alternative explanations for the consumptive coagulopathy.

The association of fever and seizures is well established. Postictal fever is common and is most frequently caused by production of excessive heat by sustained muscle activity, but underlying infection must also be considered. In a retrospective study of patients with status epilepticus and postictal fever, 38 of 90 patients had a temperature greater than 37.8°C.4 Another study found that 40 of 93 patients had a temperature higher than 37.8 °C and two higher than 39.5 °C after generalized seizure.5 In addition, electrical seizure activity by itself can lead to hyperpyrexia, as complex partial seizure activity has been reported to be a cause of fever, possibly because of seizure-related dysfunction of the hypothalamic thermoregulatory centers.6

Hyperpyrexia has been associated with DIC most often in heat stroke and malignant hyperthermia.7,8 The bleeding diathesis in heat stroke was originally thought to be caused by primary fibrinolysis, but more recent studies suggest that fibrinolysis is a secondary phenomenon and that the primary event is a consumptive coagulopathy.9 Autopsy studies of heat stroke victims have shown widespread endothelial damage, which can be the initiating event in DIC.10 The available reports, therefore, suggest that the consumptive coagulopathy associated with heat stroke includes elements of excessive thrombin generation and heightened fibrinolysis with evidence of primary endothelial damage, similar to the findings in the patient presented here.

Our case represents the third report in the English literature of the association between status epilepticus and DIC. Fisher et al2 reported a single nonfatal case of status epilepticus in a patient with rhabdomyolysis, renal failure, and hyperthermia and suggested that DIC was caused by muscle damage, hyperpyrexia, or renal failure. Another brief report presented a small series of 31 patients with status epilepticus and DIC collected from published and unpublished sources. However, multiorgan failure including renal involvement made it difficult to determine the cause of DIC in these patients.3 We propose that consumptive coagulopathy associated with status epilepticus is caused by hyperpyrexia resulting in endothelial damage, which leads to activation of coagulation and fibrinolysis. Rhabdomyolysis is likely to be secondary to the hyperpyrexia and widespread endothelial damage. Autopsy findings in our patient failed to identify other explanation such as infection, malignancy, or trauma for the coagulopathy. This association has important implications in the management of seizures because temperature should be monitored closely in patients with status epilepticus and efforts directed toward prompt lowering of body temperature to prevent the development of consumption coagulopathy. These include administration of antipyretics and the use of cooling blankets and ice packs to treat severe hyperthermia.

Footnotes

  • Supported in part by Grant No. HL-30616 from the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD.

    Received September 25, 1997. Accepted in final form March 27, 1998.

References

  1. 1.↵
    Baglin T. Disseminated intravascular coagulation: diagnosis and treatment. Br Med J 1996;312:683-687.
    OpenUrlFREE Full Text
  2. 2.↵
    Fisher SP, Lee J, Zatuchni J, et al. Disseminated intravascular coagulation in status epilepticus. Thromb Haemost 1977;38:909-913.
    OpenUrl
  3. 3.↵
    Yeun AWC, Bihari DJ. Multiorgan failure and disseminated and intravascular coagulation in severe convulsive seizures. Lancet 1992;340:618. Letter.
    OpenUrl
  4. 4.↵
    Simon RP. Physiologic consequences of status epilepticus. Epilepsia 1985;26:56-66.
    OpenUrl
  5. 5.↵
    Watchel TJ, Steele GH, Day JA. Natural history of fever following seizure. Arch Intern Med 1987;147:1571-1572.
    OpenUrl
  6. 6.↵
    Sato T. Recurrent reversible rhabdomyolysis associated with hyperthermia and status epilepticus. Acta Paediatr 1995;84:1083-1085.
    OpenUrlPubMed
  7. 7.↵
    Shibolet S, Coll R, Gilat T, et al. Heatstroke: its clinical picture and mechanisms in 36 cases. Quart J Med 1967;144:525-546.
    OpenUrl
  8. 8.
    Britt GA. Malignant hyperthermia. In: Gravenstein N, Kirby RR, eds. Complications in anesthesiology. Philadelphia: Lippincott-Raven, 1996:141-162.
  9. 9.↵
    Bouchama A, Bridley F, Hammami MM, et al. Activation of coagulation and fibrinolysis in heatstroke. Thromb Haemost 1996;76:909-915.
    OpenUrlPubMed
  10. 10.↵
    Chao TC, Sinniuah R, Pakiam JE. Acute heat stroke deaths. Pathology 1981;13:145-156.
    OpenUrlPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Brief Communications
    Multiorgan dysfunction and disseminated intravascular coagulation in children receiving lamotrigine and valproic acid
    D. S. Chattergoon, M. A. McGuigan, G. Koren et al.
    Neurology, November 01, 1997
  • Clinical/Scientific Notes
    Multisystem hypersensitivity reaction to lamotrigine
    Barbara M. Sarris, Jeffrey G. Wong et al.
    Neurology, October 01, 1999
  • Clinical/Scientific Notes
    Brainstem infarction following Korean viper bite
    Byung-Chul Lee, Sung-Hee Hwang, Jae-Chun Bae et al.
    Neurology, May 08, 2001
  • Brief Communications
    High titers of CA-125 may be associated with recurrent ischemic strokes in patients with cancer
    T. G. Jovin, V. Boosupalli, S. A. Zivkovic et al.
    Neurology, June 13, 2005
Neurology: 100 (13)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise